Form 4 Filing by Autolus Therapeutics plc Director Ryan Richardson

This filing details a Form 4 filed by Ryan Richardson, a director at Autolus Therapeutics plc, on July 1, 2026, reporting transactions from June 29, 2026. Richardson acquired 31,667 Restricted Share Units (RSUs) with a price of $0.00. These RSUs vest on June 29, 2027. Additionally, he acquired 47,500 Share Options to buy American Depositary Shares at an exercise price of $1.61. These options vest in twelve equal monthly installments starting July 29, 2026. The RSUs represent a contingent right to receive one share of the Issuer's American Depositary Shares, which are convertible into Ordinary Shares. All acquired securities are held directly by Richardson.